Ambev SA (ABEV) is not a strong buy at the moment for a beginner investor with a long-term horizon. The technical indicators are mixed, with bearish MACD and neutral RSI, and hedge funds are selling the stock aggressively. Analysts' ratings are divided, with some upgrades but also significant concerns about valuation and earnings growth. Options data suggests bearish sentiment with a high put-call volume ratio. Without clear positive catalysts or strong financial performance data, it is prudent to hold off on investing in this stock for now.
The MACD histogram is negative and expanding downward, indicating bearish momentum. RSI is neutral at 37.318, showing no clear signal. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support level is at 3.074, and resistance is at 3.28. The stock has a 50% chance to decline by -1.04% in the next day and a 10.88% chance to rise in the next month.

The stock has bullish moving averages, and Barclays recently raised its price target to $3.50, which is above the current price.
Hedge funds are aggressively selling the stock, with a 9796.69% increase in selling over the last quarter. UBS has a Sell rating with a price target below the current price, citing concerns about valuation and earnings growth. No recent news or congress trading data to support a positive outlook.
No financial data available for analysis.
Analyst ratings are mixed. BTG Pactual upgraded the stock to Buy with a R$20 price target, while UBS maintains a Sell rating with a $2.90 price target. Barclays has an Equal Weight rating with a $3.50 price target. UBS highlights concerns about valuation and earnings growth.